SARS-CoV-2 (2019-nCoV) Spike RBD(N501Y)-His Recombinant Protein for Covid 19 activity (new variant strain of Covid)

A Contract Award Notice
by PUBLIC HEALTH ENGLAND

Source
Contracts Finder
Type
Contract (Products)
Duration
3 month
Value
£11K
Sector
HEALTH
Published
22 Jan 2021
Delivery
30 Dec 2020 to 31 Mar 2021
Deadline
29 Dec 2020 17:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

The Government must protect the health and well-being of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 Jan 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020. Public Health England (PHE) discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). This requirement is in response to the recent COVID -19 outbreak. PHE has awarded a contract to Sino Biological for the purchase of SARS-CoV-2 (2019-nCoV) Spike RBD(N501Y)-His Recombinant Protein for Covid 19 activity (new variant strain of Covid) due to extreme urgency under current public procurement regulations using regulation 32(2)(c).

Award Detail

1 Sino Biological (None)
  • Value: £11,150

CPV Codes

  • 33140000 - Medical consumables
  • 33141620 - Medical kits

Indicators

  • Contract is suitable for SMEs.

Reference

Domains